Albert Bourla, chairman and chief executive officer of the pharmaceutical company Pfizer. speaks in the Oval Office of the White House, Tuesday, Sept. 30, 2025, in Washington, as from left, Secretary ...
WASHINGTON (AP) — Drugmaker Pfizer has agreed to lower drug costs and invest $70 billion in U.S. manufacturing under a deal struck with the Trump administration, President Donald Trump said Tuesday.
Could “TrumpRx” be the prescription for lower drug prices? President Donald Trump announced a landmark deal with Pfizer to cut drug prices and sell medications on TrumpRx, a direct-to-consumer federal ...
Drugmaker Pfizer has agreed to lower drug costs under a deal struck with President Donald Trump's administration.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback